AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity (original) (raw)
References
Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B and Pestell RG . (1999). J. Biol. Chem., 274, 34186–34195.
Bakiri L, Lallemand D, Bossy-Wetzel E and Yaniv M. . (2000). EMBO J., 19, 2056–2068.
Bossy-Wetzel E, Bakiri L and Yaniv M . (1997). EMBO J., 16, 1695–1709.
Brown JR, Nigh E, Lee RJ, Ye H, Thompson MA, Saudou F, Pestell RG and Greenberg ME . (1998). Mol. Cell. Biol., 18, 5609–5619.
Brown PH, Alani R, Preis LH, Szabo E and Birrer MJ . (1993). Oncogene, 8, 877–886.
Brown PH, Chen TK and Birrer MJ . (1994). Oncogene, 9, 791–799.
Chen TK, Smith LM, Gebhardt DK, Birrer MJ and Brown PH . (1996a). Mol. Carcinogen., 15, 215–226.
Chen Y, Takeshita A, Ozaki K, Kitano S and Hanazawa S . (1996b). J. Biol. Chem., 271, 31602–31606.
Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M and Rubin LL . (1995). Neuron, 14, 927–939.
Herber B, Truss M, Beato M and Muller R . (1994). Oncogene, 9, 2105–2107.
Holt JT, Gopal TV, Moulton AD and Nienhuis AW . (1986). Proc. Natl. Acad. Sci. USA, 83, 4794–4798.
Johnson RS, van Lingen B, Papaioannou VE and Spiegelman BM . (1993). Genes Dev., 7, 1309–1317.
Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M and Benz CC . (1999). Clin. Cancer Res., 5, 251–256.
Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW and Bacus SS . (2002). N. Engl. J. Med., 347, 1566–1575.
Kim HK, Park IA, Heo DS, Noh DY, Choe KJ, Bang YJ and Kim NK . (2001). Eur. J. Surg. Oncol., 27, 464–471.
Lin F, Xiao D, Kolluri SK and Zhang X . (2000). Cancer Res., 60, 3271–3280.
Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK and Brown PH . (2002). Oncogene, 21, 7680–7689.
Ludes-Meyers JH, Liu Y, Munoz-Medellin M, Hilsenbeck SG and Brown PH . (2001). Oncogene, 20, 2771–2780.
Nielsen NH, Arnerlov C, Emdin SO and Landberg G . (1996). Br. J. Cancer, 74, 874–880.
Potapova O, Basu S, Mercola D and Holbrook NJ . (2001). J. Biol. Chem., 276, 28546–28553.
Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA and Barrett JC . (1996). Mol. Cell. Biol., 16, 211–218.
Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F and Osteen KG . (1994). J. Clin. Invest., 94, 946–953.
Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S and Herlyn M . (1999). Cancer Res., 59, 4876–4881.
Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH and Osborne CK . (2000). J. Natl. Cancer Inst., 92, 1926–1934.
Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF . (1999). Genes Dev., 13, 607–619.
Schule R and Evans RM . (1991). Cold Spring Harb. Symp. Quant. Biol., 56, 119–127.
Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ . (1999). Oncogene, 18, 6063–6070.
Smith MJ and Prochownik EV . (1992). Blood, 79, 2107–2115.
Szabo E, Preis LH, Brown PH and Birrer MJ . (1991). Cell Growth Differ., 2, 475–482.
Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S and Kushner PJ . (1999). Mol. Endocrinol., 13, 1672–1685.
Weitzman JB, Fiette L, Matsuo K and Yaniv M . (2000). Mol. Cell, 6, 1109–1119.
Wisdom R, Johnson RS and Moore C . (1999). EMBO J., 18, 188–197.
Yang L, Kim HT, Munoz-Medellin D, Reddy P and Brown PH . (1997). Cancer Res., 57, 4652–4661.
Yang L, Ostrowski J, Reczek P and Brown P . (2001). Oncogene, 20, 8025–8035.
Yu Q, Geng Y and Sicinski P . (2001). Nature, 411, 1017–1021.
Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG and Kline K . (1997). Mol. Carcinogen., 19, 180–190.